Biology and management of idiopathic myelofibrosis

Current Opinion in Oncology

Volumn 13, Issue 2, 2001, Pages 91-94

  Smith, B Douglas ^a   Moliterno, Alison R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; INFLAMMATION; MEGAKARYOCYTE; MYELOFIBROSIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; HUMANS; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; PROGNOSIS;

EID: 0035083385     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200103000-00002     Document Type: Review

References (22)

1. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome
2. Myelofibrosis with myeloid metaplasia
3. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases
4. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis
5. Effective treatment of myelofibrosis (MF) by autologous peripheral blood stem cell transplantation
6. Stem cell rescue after bone marrow curettage for the treatment of myelofibrosis with myeloid metaplasia myeloproliferative disorders
7. MPLV: A retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice
8. Thrombopoietin
9. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation
10. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice
11. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis
12. Blood thrombopoietin, IL-6, and IL-11 levels in patients with agnogenic myeloid metaplasia
13. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera
14. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: A European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center collaborative study
15. Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system
16. Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis
17. Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients
18. Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: Evidence for a 'graft vs. myelofibrosis' effect
19. Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: Demonstration of a graft-versus-myelofibrosis effect
20. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
21. Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation
22. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4lg, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant